Nonpharmacological treatment and relief of symptoms in COPD

European Respiratory Journal

Volumn 32, Issue 1, 2008, Pages 218-228

  Clini, E M ^a,b   Ambrosino, N ^c,d  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Villa Pineta Hospital   (Italy)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

^d Weaning and Pulmonary Rehabilitation Unit   (Italy)

Author keywords

Dyspnoea; Noninvasive mechanical ventilation; Nutrition; Oxygen; Rehabilitation; Thoracic surgery

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BRONCHODILATING AGENT; FLUOXETINE; METHADONE; OPIATE DERIVATIVE; PAROXETINE; PLACEBO;

ANXIETY; ARTICLE; BODY COMPOSITION; BREATHING EXERCISE; BULLECTOMY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; DEPRESSION; DIET THERAPY; DISEASE SEVERITY; DYSPNEA; HUMAN; HYPERCAPNIA; LONG TERM CARE; LUNG EMPHYSEMA; LUNG RESECTION; LUNG SURGERY; LUNG TRANSPLANTATION; MENTAL DISEASE; MUSCLE TRAINING; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; OXYGEN THERAPY; PALLIATIVE THERAPY; PATIENT EDUCATION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; PULMONARY REHABILITATION; QUALITY OF LIFE; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT OUTCOME; EXERCISE TOLERANCE; KINESIOTHERAPY; REVIEW; SMOKING CESSATION;

EXERCISE THERAPY; EXERCISE TOLERANCE; HUMANS; OXYGEN INHALATION THERAPY; PALLIATIVE CARE; POSITIVE-PRESSURE RESPIRATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SMOKING CESSATION;

EID: 52749097037     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00134007     Document Type: Article

References (155)

1. Mannino DM, Buist S. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765-773.
2. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
3. Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996; 154: 959-967.
4. Rivera-Fernandez R, Navarrete-Navarro P, Fernández-Mondejar E, et al. Six-year mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease. Crit Care Med 2006; 34: 2317-2324.
5. Hoogendoorn M, Feenstra TL, Shermer TRJ, Hesselink AE, Rutten M, Van Molken MPMH. Severity distribution of chronic obstructive pulmonary disease in Dutch general practice. Respir Med 2006; 100: 83-86.
6. Zielinski J, Bednarek M, Górecka D, et al. Increasing COPD awareness. Eur Respir J 2006; 27: 833-852.
7. Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875-1881.
8. Friedman M, Hilleman DE. Economic burden of chronic obstructive pulmonary disease. Impact of new treatment options. Pharmacoeconomics 2001; 19: 245-254.
9. Miratvilles M, Murio C, Guerrero T, Gisbert R, on behalf of the DAFNE Study Group. Cost of chronic bronchitis and COPD. A 1-year follow-up study. Chest 2003; 123: 784-791.
10. Miratvilles M, Murio C, Guerrero T, Gisbert R, on behalf of the DAFNE Study Group. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002; 121: 1449-1455.
11. Faulkner MA, Hilleman DE. The economic impact of chronic obstructive pulmonary disease. Expert Opin Pharmacother 2002; 3: 219-228.
12. Field MJ, Cassel CK. Approaching Death: Improving Care at the End of Life. Institute of Medicine Report. Washington, National Academy Press, 1997.
13. Mannino DM, Doherty DE, Buist SA. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006; 100: 115-122.
14. Clini E, Costi S, Lodi S, Rossi G. Non-pharmacological treatment for chronic obstructive pulmonary disease. Med Sci Monit 2003; 9: RA300-RA305.
15. Sandland CJ, Singh SJ, Curcio A, Jones PM, Morgan MD. A profile of daily activity in chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2005; 25: 181-183.
16. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-1413.
17. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 2007; 131: Suppl. 5, 4S-42S.
18. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease. A population-based cohort study. Am J Respir Crit Care Med 2007; 175: 458-463.
19. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61: 772-778.
20. Mercken EM, Hageman GJ, Schols AM, Akkermans MA, Bast A, Wouters EF. Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 994-1001.
21. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006; 4: CD003793.
22. Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 2005; 26: 630-636.
23. Foglio K, Bianchi L, Bruletti G, et al. Seven-year course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs. Respir Med 2007; 101: 1961-1970.
24. Carone M, Patessio A, Ambrosino N, et al. Effect of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): the Maugeri Study. Respir Med 2007; 101: 2447-2453.
25. Clini E, Ambrosino N. Early physiotherapy in the respiratory intensive care unit. Respir Med 2005; 99: 1096-1104.
26. Porta R, Vitacca M, Gilè LS, et al. Supported arm training in patients recently weaned from mechanical ventilation. Chest 2005; 128: 2511-2520.
27. Martin UJ, Hincapie L, Nimchuk M, Gaughan J, Criner GJ. Impact of whole-body rehabilitation in patients receiving chronic mechanical ventilation. Crit Care Med 2005; 33: 2259-2265.
28. Nuhr M, Crevenna R, Gohlsch B, et al. Functional and biochemical properties of chronically stimulated human skeletal muscle. Eur J Appl Physiol 2003; 89: 202-208.
29. Ambrosino N, Strambi S. New strategies to improve exercise tolerance in COPD. Eur Respir J 2004; 24: 313-322.
30. Neder JA, Sword D, Ward SA, Mackay E, Cochrane LM, Clark CJ. Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax 2002; 57: 333-337.
31. Bourjeily-Habr G, Rochester CL, Palermo F, Snyder P, Mohsenin V. Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease. Thorax 2002; 57: 1045-1049.
32. Zanotti E, Felicetti G, Maini M, Fracchia C. Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation. Effect of electrical stimulation. Chest 2003; 124: 292-296.
33. Vivodtzev I, Pépin JL, Vottero G, et al. Improvement in quadriceps strength and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished COPD. Chest 2006; 129: 1540-1548.
34. Dal Corso S, Napolis L, Malaguti C, et al. Skeletal muscle structure and function in response to electrical stimulation in moderately impaired COPD patients. Respir Med 2007; 101: 1236-1243.
35. Ambrosino N, Palmiero G, Strambi S. New approaches in pulmonary rehabilitation. Clin Chest Med 2007; 28: 629-638.
36. Rochester C. Innovative approaches in muscle training: transcutaneous electrical muscle stimulation. In: Ambrosino N, Goldstein RS, eds. Ventilatory Support for Chronic Respiratory Failure. New York, Informa Healthcare, 2008; pp 145-165.
37. Maillefert JF, Eicher JC, Walker P, et al. Effects of low-frequency electrical stimulation of quadriceps and calf muscles in patients with chronic heart failure. J Cardiopulm Rehabil 1998; 18: 277-282.
38. Quittan M, Wiesinger GF, Sturm B, et al. Improvement of thigh muscles by neuromuscular electrical stimulation in patients with refractory heart failure: a single-blind, randomized, controlled trial. Am J Phys Med Rehabil 2001; 80: 206-214.
39. Harris S, LeMaitre JP, Mackenzie G, Fox KA, Denvir MA. A randomized study of home-based electrical stimulation of the legs and conventional bicycle exercise training for patients with chronic heart failure. Eur Heart J 2003; 24: 871-878.
40. Deley G, Kervio G, Verges B, et al. Comparison of low-frequency electrical myostimulation and conventional aerobic exercise training in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 2005; 12: 226-233.
41. Mitrouska I, Tzanakis N, Siafakas NM. Oxygen therapy in chronic obstructive pulmonary disease. In: Siafakas NM, ed. Management of Chronic Obstructive Pulmonary Diease. Eur Respir Mon 2006; 38: 302-312.
42. Tarpy SP, Celli BR. Long-term oxygen therapy. N Engl J Med 1995; 333: 710-714.
43. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S77-S121.
44. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398-1420.
45. Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med 2003; 168: 1034-1042.
46. Bradley JM, Lasserson T, Elborn S, MacMahon J, O'Neill B. A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD. Chest 2007; 131: 278-285.
47. Snider GL. Enhancement of exercise performance in COPD patients by hyperoxia. Chest 2002; 122: 1830-1836.
48. van Helvoort HAC, Heijdra YF, Heunks LMA, et al. Supplemental oxygen prevents exercise-induced oxidative stress in muscle-wasted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 1122-1129.
49. Garrod R, Paul EA, Wedzicha JA. Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax 2000; 55: 539-543.
50. McDonald CF, Blyth CM, Lazarus MD, Marschner I, Barter CE. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia. Am J Respir Crit Care Med 1995; 152: 1616-1619.
51. Rooyackers JM, Dekhuijzen PN, Van Herwaarden CL, Folgering HT. Training with supplemental oxygen in patients with COPD and hypoxaemia at peak exercise. Eur Respir J 1997; 10: 1278-1284.
52. Nonoyama M, Brooks D, Lacasse Y, Guyatt G, Goldstein R. Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007; 2: CD005372.
53. Nonoyama M, Brooks D, Guyatt G, Goldstein R. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med 2007; 176: 343-349.
54. Petty TL, O'Donohue WJ Jr. Further recommendations for prescribing, reimbursement, technology development, and research in long-term oxygen therapy. Summary of the Fourth Oxygen Consensus Conference, Washington, D.C., October 15-16, 1993. Am J Respir Crit Care Med 1994; 150: 875-877.
55. Croxton TL, Bailey WC, for the NHLBI Working Group on Long-term Oxygen Treatment in COPD. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research. An NHLBI Workshop Report. Am J Respir Crit Care Med 2006; 174: 373-378.
56. Albert P, Calverley PMA. Drugs (including oxygen) in severe COPD. Eur Respir J 2008; 31: 1114-1124.
57. Lederer DJ, Arcasoy SM. Update in surgical therapy for chronic obstructive pulmonary disease. Clin Chest Med 2007; 28: 639-653.
58. Laros CD, Gelissen HJ, Bergstein PG, et al. Bullectomy for giant bullae in emphysema. J Thorac Cardiovasc Surg 1986; 91: 63-70.
59. Cooper JD, Trulock EP, Triantafillou AN, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995; 109: 106-116.
60. Criner G, Cordova FC, Leyenson V, et al. Effect of lung volume reduction surgery on diaphragm strength. Am J Respir Crit Care Med 1998; 157: 1578-1585.
61. Martinez FJ, De Oca MM, Whyte RI, Stetz J, Gay SE, Celli BR. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med 1997; 155: 1984-1990.
62. Geddes D, Davies M, Koyama H, et al. Effect of lung-volume-reduction surgery in patients with severe emphysema. N Engl J Med 2000; 343: 239-245.
63. Cooper JD, Patterson GA, Sundaresan RS, et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 1996; 112: 1319-1329.
64. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001; 345: 1075-1083.
65. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348: 2059-2073.
66. Criner GJ, Scharf SM, Falk JA, et al. Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema. Am J Respir Crit Care Med 2007; 176: 253-260.
67. Washko GR, Fan VS, Ramsey SD, et al. The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med 2008; 177: 164-169.
68. Venuta F, Rendina EA, De Giacomo T, et al. Bronchoscopic procedures for emphysema treatment. Eur J Cardiothorac Surg 2006; 29: 281-287.
69. Pompeo E, Mineo TC. Two-year improvement in multidimensional body mass index, airflow obstruction, dyspnea, and exercise capacity index after nonresectional lung volume reduction surgery in awake patients. Ann Thorac Surg 2007; 84: 1862-1869.
70. Ingenito EP, Tsai LW. Evolving endoscopic approaches for treatment of emphysema. Semin Thorac Cardiovasc Surg 2007; 19: 181-189.
71. Chang AC, Chan KM, Martinez FJ. Lessons from the National Emphysema Treatment Trial. Semin Thorac Cardiovasc Surg 2007; 19: 172-180.
72. Reilly J, Washko G, Pinto-Plata V, et al. Biological lung volume reduction. A new bronchoscopic therapy for advanced emphysema. Chest 2007; 131: 1108-1113.
73. Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. Transplantation 1998; 66: 951-956.
74. Pierson RN. Lung transplantation: current status and challenges. Transplantation 2006; 81: 1609-1615.
75. Trulock EP, Christie JD, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 2007; 26: 782-795.
76. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of LTx for end-stage lung disease. Lancet 1998; 351: 24-27.
77. Ambrosino N, Bruschi C, Callegari G, et al. Time course of exercise capacity, and skeletal and respiratory muscle performance after heart-lung transplantation. Eur Respir J 1996; 9: 1508-1514.
78. Gay SE, Martinez FJ. Pulmonary rehabilitation and transplantation. In: Donner CF, Ambrosino N, Goldstein RS, eds. Pulmonary Rehabilitation. London, Hodder Arnold, 2005; pp. 304-311.
79. International Society for Heart & Lung Transplantation, ISHLT Transplant Registry Quarterly Reports. www.ishlt.org/registries/ quarterlyDataReport.asp Date last updated: January 4, 2008. Date last accessed: December 24, 2007.
80. Studer SM, Levy RD, McNeil K, Orens JB. Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness. Eur Respir J 2004; 24: 674-685.
81. Hanania NA, Ambrosino N, Calverley P, Cazzola M, Donner CF, Make B. Treatments for COPD. Respir Med 2005; 99: Suppl. B, S28-S40.
82. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation - a consensus conference report. Chest 1999; 116: 521-534.
83. Muir JF, Cuvelier A, Tenang B, European task force on mechanical ventilation COPD. Long-term home nasal intermittent positive pressure ventilation (NIPPV) plus oxygen therapy (LTOT) versus LTOT alone in severe hypercapnic COPD. Preliminary results of a European multicentre trial. Am J Respir Crit Care Med 1997; 155: A408.
84. Clini E, Sturani C, Rossi A, et al. The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J 2002; 20: 529-538.
85. Clini E, Sturani C, Porta R, et al. Outcome of COPD patients performing nocturnal non-invasive mechanical ventilation. Respir Med 1998; 92; 1215-1222.
86. Garrod R, Mikelsons C, Paul EA, Wedzicha JA. Randomized controlled trial of domiciliary noninvasive positive pressure ventilation and physical training in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 1335-1341.
87. Kolodziej MA, Jensen L, Rowe B, Sin D. Systematic review of noninvasive positive pressure ventilation in severe stable COPD. Eur Respir J 2007; 30: 293-306.
88. O'Donnell DE, Sanii R, Younes M. Improvement in exercise endurance in patients with chronic airflow limitation using continuous positive airway pressure. Am Rev Respir Dis 1988; 138: 1510-1514.
89. Keilty SE, Ponte J, Fleming TA, Moxham J. Effect of inspiratory pressure support on exercise tolerance and breathlessness in patients with severe stable chronic obstructive pulmonary disease. Thorax 1994; 49: 990-996.
90. Bianchi L, Foglio K, Pagani M, Vitacca M, Rossi A, Ambrosino N. Effects of proportional assist ventilation on exercise tolerance in COPD patients with chronic hypercapnia. Eur Respir J 1998; 11: 422-427.
91. Bianchi L, Foglio K, Porta R, Baiardi R, Vitacca M, Ambrosino N. Lack of additional effect of adjunct of assisted ventilation to pulmonary rehabilitation in mild COPD patients. Respir Med 2002; 96: 359-367.
92. Hawkins P, Johnson LC, Nikoletou D, et al. Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease. Thorax 2002; 57: 853-859.
93. Van t'Hul A, Gosselink R, Hollander P, Postmus P, Kwakkel G. Training with inspiratory pressure support in patients with severe COPD. Eur Respir J 2006; 27: 65-72.
94. Ambrosino N. Assisted ventilation as an aid to exercise training: a mechanical doping? Eur Respir J 2006; 27: 3-5.
95. Dreher M, Storre JH, Windisch W. Noninvasive ventilation during walking in patients with severe COPD: a randomised cross-over trial. Eur Respir J 2007; 29: 930-936.
96. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007; 29: 1224-1238.
97. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847-852.
98. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-1422.
99. Soler-Cataluna JJ, Martinez-Garcia MA, Roman SP, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-931.
100. Dewan NA, Rafique S, Kanwar B, et al. Acute exacerbation of COPD: factors associated with poor treatment outcome. Chest 2000; 117: 662-671.
101. Fabbri LM, Luppi F, Beghé B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31: 204-212.
102. Garcia-Aymerich J, Monsó E, Marrades RM, et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med 2001; 164: 1002-1007.
103. Esteban A, Ferguson ND, Meade MO, et al. Evolution of mechanical ventilation in response to clinical research. Am J Respir Crit Care Med 2008; 177: 170-177.
104. Ambrosino N, Vagheggini G. Noninvasive positive pressure ventilation in the acute care setting: where are we? Eur Respir J 2008; 31: 874-886.
105. Hill NS, Brennan J, Garpestad E, Nava S. Noninvasive ventilation in acute respiratory failure. Crit Care Med 2007; 35: 2402-2407.
106. Levy M, Tanios MA, Nelson D, et al. Outcomes of patients with do-not-intubate orders treated with noninvasive ventilation. Crit Care Med 2004; 32: 2002-2007.
107. Schettino G, Altobelli N, Kacmarek RM. Noninvasive positive pressure ventilation reverses acute respiratory failure in selected "do-not- intubate" patients. Crit Care Med 2005; 33: 1976-1982.
108. Chu C-M, Chan VL, Wong IWY, Leung W, Lin AWN, Cheung K-F. Noninvasive ventilation in patients with acute hypercapnic exacerbation of chronic obstructive pulmonary disease who refused endotracheal intubation. Crit Care Med 2004; 32: 372-377.
109. Nava S, Sturani C, Hartl S, et al. End-of-life decision-making in respiratory intermediate care units: a European survey. Eur Respir J 2007; 30: 156-164.
110. Cuomo A, Delmastro M, Ceriana P, et al. Noninvasive mechanical ventilation as a palliative treatment of acute respiratory failure in patients with end-stage solid cancer. Palliat Med 2004; 18: 602-610.
111. Curtis JR, Cook DJ, Sinuff T, et al. Noninvasive positive pressure ventilation in critical and palliative care settings: understanding the goals of therapy. Crit Care Med 2007; 35: 932-939.
112. Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 2002; 20: 539-544.
113. Jee SH, Sull JW, Park J, et al. Body-mass index and mortality in Korean men and women. N Engl J Med 2006; 355: 779-787.
114. Schols AMWJ, Wouters EFM. Nutrition and metabolic therapy. In: Donner CF, Ambrosino N, Goldstein RS, eds. Pulmonary Rehabilitation. London, Hodder Arnold, 2005; pp. 229-235.
115. Hallin R, Gudmundsson G, Suppli Ulrik C, et al. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med 2007; 101: 1954-1960.
116. Sivasothy P, Smith IE, Shneerson JM. Mask intermittent positive pressure ventilation in chronic hypercapnic respiratory failure due to chronic obstructive pulmonary disease. Eur Respir J 1998; 11: 34-40.
117. Wouters EFM. Chronic obstructive pulmonary disease. Systemic effects of COPD. Thorax 2002; 57: 1067-1070.
118. Debigarè R, Cote CH, Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1712-1717.
119. Ambrosino N, Clini E. Long-term mechanical ventilation and nutrition. Respir Med 2004; 98: 413-420.
120. Schols AM, Slangen J, Volovics L, Wouters EFM. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157; 1791-1797.
121. Schols AMWJ, Soeters PB, Mostert R, Pluymers RJ, Wouters EFM. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: 1268-1274.
122. Burdet L, de Muralt B, Schutz Y, Pichard C, Fitting JW. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective randomized, controlled study. Am J Respir Crit Care Med 1997; 156: 1800-1806.
123. Pingleton SK. Enteral nutrition in patients with respiratory disease. Eur Respir J 1996; 9: 364-370.
124. Aubier M, Murciano D, Lecocguic Y. Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med 1985; 313: 420-424.
125. Ellis DA. Intermediate metabolism of muscle in Duchenne muscular dystrophy. Br Med Bull 1980; 36: 165-171.
126. Gronberg AM, Slinde F, Engstrom CP, Hulthen L, Larsson S. Dietary problems in patients with severe chronic obstructive pulmonary disease. J Hum Nutr Diet 2005; 18: 445-452.
127. Elpern EH, Scott MG, Petro L, Ries MH. Pulmonary aspiration in mechanically ventilated patients with tracheostomies. Chest 1994; 105: 563-566.
128. Vitacca M, Callegari G, Sarvà M, et al. Physiological effects of meals in difficult-to-wean tracheostomised patients with chronic obstructive pulmonary disease. Intensive Care Med 2005; 31: 236-242.
129. Anker SD, John M, Pedersen PU, et al. ESPEN guidelines on enteral nutrition: cardiology and pulmonology. Clin Nutr 2006; 25: 311-318.
130. Ferreira IM, Brooks D, Lacasse Y, Goldstein RS, White J. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005; 2: CD000998.
131. Ambrosino N, Di Giorgio M, Di Paco A. Strategies to improve breathlessness and exercise tolerance in chronic obstructive pulmonary disease. Respir Med COPD Update 2006; 2: 2-8.
132. Ambrosino N, Simonds A. The clinical management in extremely severe COPD. Respir Med 2007; 101: 1613-1624.
133. Luce JM, Luce JA. Management of dyspnea in patients with far-advanced lung disease. JAMA 2001; 285: 1331-1337.
134. Kallet RH. The role of inhaled opioids and furosemide for the treatment of dyspnea. Respir Care 2007; 52: 900-910.
135. Juan G, Ramón M, Valia JC, et al. Palliative treatment of dyspnea with epidural methadone in advanced emphysema. Chest 2005; 128: 3322-3328.
136. Dyspnea, mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med 1999; 159: 321-340.
137. Palange P, Crimi E, Pellegrino R, Brusasco V. Supplemental oxygen and heliox: "new" tools for exercise training in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2005; 11: 145-148.
138. O'Donnell DE, D'Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 892-898.
139. Palange P, Valli G, Onorati P, et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol 2004; 97: 1637-1642.
140. Laude EA, Duffy NC, Baveystock C, et al. The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease. A randomized crossover trial. Am J Respir Crit Care Med 2006; 173: 865-870.
141. Peveler R, Carson A, Rodin G. ABC of psychological medicine. Depression in medical patients. BMJ 2002; 325: 149-152.
142. Yohannes AM, Baldwin RC, Connolly MJ. Mood disorders in elderly patients with chronic obstructive pulmonary disease. Rev Clin Gerontol 2000; 10: 193-202.
143. Wagena EJ, Arrindell WA, Wouters EFM, van Schayck CP. Are patients with COPD psychologically distressed? Eur Respir J 2005; 26: 242-248.
144. Van Manen JG, Bindels PJ, Dekker FW, Ljzermans CJ, van der Zee JS, Schadé E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002; 57: 412-416.
145. Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005; 127: 1205-1211.
146. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly patients with chronic obstructive pulmonary disease. Age Ageing 2006; 35: 457-459.
147. Yohannes AM, Connolly MJ, Baldwin RC. A feasibility of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry 2001; 16: 451-454.
148. Lacasse Y, Beaudoin L, Rousseau L, Maltais F. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis 2004; 61: 140-147.
149. Kunik ME, Braun U, Stanley MA, et al. One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med 2001; 31: 599-606.
150. Withers NJ, Rudkin ST, White RJ. Anxiety and depression in severe chronic obstructive pulmonary disease: the effects of pulmonary rehabilitation. J Cardiopulm Rehabil 1999; 19: 362-365.
151. Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychological and cognitive outcomes of a randomised trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol 1998; 17: 232-240.
152. Paz-Diaz H, Montes de Oca M, Lopez JM, Celli BR. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil 2007; 86: 30-36.
153. Ambrosino N, Bruletti G, Scala V, Porta R, Vitacca M. Cognitive and perceived health status in patients recovering from an acute exacerbation of COPD. A controlled study. Intensive Care Med 2002; 28: 170-177.
154. Crews WD, Jefferson AL, Bolduc T, et al. Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease. Arch Clin Neuropsychol 2001; 16: 643-652.
155. Habraken JM, Willems DL, de Kort SJ, Bindels PJ. Health care needs in end-stage COPD: a structured literature review. Patient Educ Couns 2007; 68: 121-130.